Signos – a comprehensive metabolic health platform that includes a proprietary AI engine with a continuous glucose monitor (CGM) to provide real-time data and recommendations for healthy weight management – recently announced $20 million in Series B funding to respond to the obesity and metabolic health crisis plaguing the US. This new funding round will enable Signos to expand its core team and platform and conduct additional research on metabolic health. The round was led by Cheyenne Ventures and GV (Google Ventures), with additional funding from Dexcom Ventures and Samsung Next.
Glucose management and weight gain are major challenges and over 96 million Americans are prediabetic. Plus, it is estimated that 1 billion people are projected to have diabetes by 2050. With early detection and simple lifestyle changes, Signos currently offers a metabolic-led solution for reversing prediabetes and aiding those on their weight loss journey. Previously only available for non-diabetics, Signos has expanded its weight management platform to support people living with Type 2 diabetes in May 2023.
Signos’ app enables members to log what they eat and how much they exercise, enabling the Signos AI platform to learn how one’s metabolism reacts to different foods and fitness patterns. And Signos then provides data-driven personalized recommendations based on an individual’s unique metabolic profile.
KEY QUOTES:
“Sleep, stress, exercise, and diet all influence how high and sustained one’s glucose spikes can be. We often don’t realize that people make around 227 food-related decisions a day. By providing glucose visibility, tracking and AI-driven proactive suggestions, Signos can help you navigate those choices for better health.”
— Sharam Fouladgar-Mercer, CEO of Signos
“You can’t manage what you don’t measure. Signos takes a data-driven approach to weight and overall health, which has the potential to create strong, long-lasting outcomes for people everywhere. Signos is changing how people approach everyday decisions—about diet, exercise, sleep, etc.—by providing a deeper understanding of metabolic health and personalized weight care.”
— Jay Fulcher, Managing Partner, Cheyenne Ventures
